drugset / Trial / NCT03508830
Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
The Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial is a single center, double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.
Timeline
- Start
- 2018-12-30
- Primary completion
- 2021-01-30
- Completion
- 2021-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |